National Cancer Institute (NCI): all 3,554 studies

Page 25 of 36. Open to participants first (334), then studies with results posted, then the rest; newest registration first within each.

• Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver FunctionCompletedNCT00674024Phase 1
• Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By SurgeryActive, not recruitingNCT00669734Phase 1
• Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed GlioblastomaCompletedNCT00662506Phase 1/2
• Follow-Up Study of Kidney Cancer PatientsCompletedNCT00656955
• Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant GliomaCompletedNCT00650923Phase 1
• Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With AngiogenesisCompletedNCT00646555
• SNX-5422 to Treat Solid Tumor Cancers and LymphomasCompletedNCT00644072Phase 1
• A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast CancerCompletedNCT00637481Phase 1
• Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck CancerCompletedNCT00629226Phase 1
• Aflibercept in Treating Young Patients With Relapsed or Refractory Solid TumorsCompletedNCT00622414Phase 1
• Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic LeukemiaTerminatedNCT00612612Phase 1
• IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid TumorCompletedNCT00609141Phase 1
• Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT00608361Phase 1
• Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinum ChemotherapyCompletedNCT00602277Phase 1
• Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)CompletedNCT00590785Phase 3
• Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative DisordersCompletedNCT00588991Phase 1
• Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by SurgeryCompletedNCT00576654Phase 1
• Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral LeukoplakiaTerminatedNCT00571558Phase 1
• 1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By SurgeryCompletedNCT00567931Phase 1
• Studying a Quality of Life Questionnaire in Patients With Colorectal CancerCompletedNCT00564694
• Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage DisequilibriumCompletedNCT00559767
• A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in ChinaCompletedNCT00559065
• Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and LymphomasCompletedNCT00553189Phase 1
• R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung CancerCompletedNCT00544596Phase 1
• Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin LymphomaTerminatedNCT00538187Phase 1
• Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid CancerCompletedNCT00535119Phase 1
• PRelationship Between Physical Activity and Cancer RisCompletedNCT00521651
• Sunitinib Malate in Treating East African Patients With Kaposi SarcomaWithdrawnNCT00521092Phase 2
• Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast CancerCompletedNCT00516243Phase 1
• Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate CancerTerminatedNCT00512668Phase 1
• Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver DysfunctionCompletedNCT00499811Phase 1
• Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid TumorsCompletedNCT00499135Phase 1
• HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of BiomarkersCompletedNCT00491335
• Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy PatientsCompletedNCT00489372Phase 1
• Smoky Coal Exposure, Genetic Susceptibility, and Lung Cancer in Non-Smoking Women in ChinaCompletedNCT00482118
• Relationship of Genetic Differences to the Development of Chromosome AbnormalitiesTerminatedNCT00481793
• Benign Reproductive Tissue Analysis for Endometrial Cancer MarkersCompletedNCT00481754
• Cancer Markers Associated With Occupational Exposure to TrichloroethyleneCompletedNCT00481611
• Radiation Exposure and Thyroid Disease in KazakhstanCompletedNCT00480428
• Breast Mammogram and Tissue StudyCompletedNCT00475761
• Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute LeukemiaCompletedNCT00470197Phase 1
• Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid TumorsCompletedNCT00462553Phase 1
• Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the ProstateCompletedNCT00459407Phase 1
• GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous LeukemiaCompletedNCT00459212Phase 1
• Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck CancerCompletedNCT00458978Phase 2
• Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaCompletedNCT00458731Phase 1
• Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine TumorsStatus unknownNCT00454376
• Lycopene in Healthy Male ParticipantsCompletedNCT00450957Phase 1
• Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00450879Phase 1
• Esophageal Cancer in Northeastern IranCompletedNCT00450788
• Safety of Batracylin in Patients With Solid Tumors and LymphomasCompletedNCT00450502Phase 1
• Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate CancerCompletedNCT00450229Phase 1
• Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi DeltaCompletedNCT00443313
• Sorafenib in Treating Patients With Advanced Solid TumorsTerminatedNCT00436579Phase 1
• Human Papillomavirus (HPV) and Risk of Cervical Precancer and CancerCompletedNCT00435214
• Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By SurgeryCompletedNCT00433576Phase 1
• Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant GliomaTerminatedNCT00430079Not applicable
• HGS-ETR2 to Treat Children With Solid TumorsTerminatedNCT00428272Phase 1
• Follow-up of Breast Cancer and Multiple Myeloma Patients Previously Enrolled in NIH Gene Therapy StudiesCompletedNCT00427726
• Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00415324Phase 1
• Chordoma Family StudyCompletedNCT00410670
• Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by SurgeryCompletedNCT00410553Phase 1
• Cancer Risk in X-Ray Technologists: Second SurveyCompletedNCT00410475
• Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00408655Phase 1
• Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple MyelomaCompletedNCT00398515Phase 1
• Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With GemcitabineCompletedNCT00397787Phase 2
• Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
• Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate CancerCompletedNCT00394511Phase 3
• Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC FamiliesTerminatedNCT00393224
• Diindolylmethane in Healthy VolunteersCompletedNCT00392652Phase 1
• Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid LeukemiaActive, not recruitingNCT00392353Phase 1/2
• 3-AP in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT00390052Phase 1
• Sunitinib in Treating Young Patients With Refractory Solid TumorsCompletedNCT00387920Phase 1
• Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by BevacizumabCompletedNCT00387374Phase 2
• Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast PhaseCompletedNCT00383474Phase 1
• Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the UterusCompletedNCT00378911Phase 2
• Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaTerminatedNCT00377104Phase 1
• Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung CancerTerminatedNCT00369551Phase 1
• AFP464 in Treating Patients With Advanced Solid TumorsTerminatedNCT00369200Phase 1
• Rosiglitazone Maleate in Treating Patients With Oral LeukoplakiaCompletedNCT00369174Phase 2
• Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaCompletedNCT00363272Phase 1
• Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte LeukemiaTerminatedNCT00360776Phase 2
• Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other DiseasesCompletedNCT00357708Phase 1
• Bevacizumab and Sunitinib in Treating Patients With Solid TumorsCompletedNCT00357318Phase 1
• Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative DisordersCompletedNCT00357305Phase 1
• Ispinesib in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00354250Phase 2
• PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or LymphomaTerminatedNCT00354185Phase 1
• Agriculture Health StudyActive, not recruitingNCT00352924
• Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other DiseasesCompletedNCT00351975Phase 1
• Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaCompletedNCT00349206Phase 1
• PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or LymphomasCompletedNCT00348985Phase 1
• AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By SurgeryCompletedNCT00348699Phase 1
• Genetic Susceptibility to Factor VIII InhibitorsCompletedNCT00344435
• Pilot Study of Inflammatory Breast Cancer in Egypt and TunisiaCompletedNCT00344071
• Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) StudyCompletedNCT00342992
• Characterization of the Pharmacokinetics of Oral Selenium Compounds in Humans Before and Following SupplementationCompletedNCT00342966
• Study of Health Effects of Cosmetic Breast AugmentationCompletedNCT00342953
• Case-Control Study of Pesticides and Childhood LeukemiaCompletedNCT00342888
• The New England Bladder Cancer StudyCompletedNCT00342875
• Analysis of Tissues From Patients in Trial of Myo-Inositol to Prevent Lung CancerCompletedNCT00342836Phase 1

← National Cancer Institute (NCI) overview and focus areas